No Data
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $589
Morgan Stanley analyst Erin Wright maintains $IDEXX Laboratories Inc(IDXX.US)$ with a buy rating, and adjusts the target price from $596 to $589.According to TipRanks data, the analyst has a success
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $589 From $596, Maintains Overweight Rating
IDEXX Laboratories (IDXX) has an average outperform rating and a price target range of $400 to $641, according to analysts polled by Capital IQ.Price: 484.01, Change: +1.31, Percent Change: +0.27
Shareholders Are Optimistic That IDEXX Laboratories (NASDAQ:IDXX) Will Multiply In Value
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $510
Stifel analyst Jonathan Block maintains $IDEXX Laboratories Inc(IDXX.US)$ with a hold rating, and maintains the target price at $510.According to TipRanks data, the analyst has a success rate of 48.5%
P/E Ratio Insights for IDEXX Laboratories
In the current market session, IDEXX Laboratories Inc. (NASDAQ:IDXX) price is at $487.60, after a 0.87% increase. However, over the past month, the stock fell by 3.66%, and in the past year, by 9.18%.
TMO or IDXX: Which Is the Better Value Stock Right Now?